Latest

UBS secures softer capital rules, saving hundreds of millions annually
Swiss regulator approves partial use of AT1 bonds, easing UBS’s capital requirements amid post-Credit Suisse reforms

DAX Falls 1.7% on Oil Above $100, Eyes ECB Rate Decision
The DAX dropped to its lowest level since late July as Brent crude breached $100, while investors awaited Thursday's expected ECB rate hike.

AEG Unveils New Appliances at IFA 2026, Backed by Strong German Growth
The Electrolux-owned brand showcased smart kitchen and laundry innovations at Berlin's trade show, as parent company Electrolux projects $0.20 EPS and modest 1% revenue growth for 2026.

SMI Falls Below 14,000 as Oil Hits $100; Meta and Chime Lead Gainers
Switzerland's SMI slipped below 14,000 for the first time since mid-June on rising oil and inflation fears. Meta rose around 5% ahead of its AI agent launch, while Chime jumped 11% on a $590 million bank acquisition.

OECD Raises Switzerland Growth Forecast Sharply for 2026
The OECD now expects Swiss GDP to expand 2.0% in 2026, up from a 1.1% June projection, citing strong domestic demand and a resilient chemical and pharma sector.

US markets open lower; SMI falls 1.2% with UBS leading declines
The SMI dropped 1.22% to 13,708.71 as oil prices near $108 and the 10-year Treasury yield hit 5.041% weighed on equities. UBS led losers in Switzerland.

UBS's Kunkel sees broadening rally, warns of three key risks
The UBS global family and institutional wealth CIO anticipates widening equity gains driven by earnings, while flagging oil shocks, AI monetisation doubts and fiscal pressures as top threats.

SMI Drops Below 14,000 for First Time Since Mid-June as Energy Fears Weigh
Switzerland's benchmark index falls to 13,919 as oil pushes past $100 a barrel and 19 of 20 SMI blue chips trade lower. Chime Financial surges nearly 11% in US premarket.

Bitcoin Suisse to Cut Up to Half Its Swiss Staff in Restructuring Push
The Zug-based crypto firm is laying off up to 50% of its local workforce as it pivots from domestic trading to global wealth management, relocating back-office operations to Bratislava and Vietnam.

Swiss Equity Favorites Add Two New Laggards; Sandoz Sets Ambitious 2035 Targets
Partners Group and Dätwyler anchor the bottom of the watchlist, while Sandoz unveils a plan to double revenue to over $22 billion by 2035.

Covenant to build long-range cruise missiles in Germany
US-Israeli defense startup Covenant plans Leipzig production of its Anthem missile for European customers, targeting 5,000 units a year from 2027.

Swiss SMI falls below 14,000 as Brent oil hits $100
Switzerland's benchmark index slipped to its lowest level since mid-June amid oil-driven inflation worries, while luxury, construction and pharma stocks diverged.

Dax recovers losses amid oil price and bond yield developments
German stock market recovers from early losses, supported by easing oil prices, bond yields, and government measures to address high fuel prices. Rüstungsaktien and steel stocks lead gains, while chemical and bank stocks lag.

Swiss shares fall as SMI slips below 14,000; DocMorris jumps on bond
SMI trades below 14,000 after weak US cues and high energy prices; Novartis lag after downgrade, luxury names fall, DocMorris rises on 100m CHF convertible.

FTSE 100 drops 1.3% as Gulf strikes push Brent above $100
European shares retreated as oil surged above $100 following Iranian attacks on shipping and US forces, with markets pricing in a persistent risk premium.

Swiss stocks fall as oil pressure hits UBS, Richemont; Adecco, Barry Callebaut rise
Swiss shares slipped midweek on oil prices and US weakness, with Novartis, UBS and Richemont under pressure while Adecco, DocMorris and Barry Callebaut moved sharply.

Swiss equities open lower as SMI falls, Novartis under pressure
The Swiss Market Index drops 0.6% to 13,979 points, with only three SMI stocks gaining. Novartis faces renewed pressure, while Adecco and Barry Callebaut perform well.

Swiss SMI set lower; 19 of 20 SMI stocks down, DocMorris and Barry Callebaut in focus
Swiss equities are seen lower before the open, with 19 of 20 SMI shares down; DocMorris falls on a new convertible bond while Barry Callebaut steadies on a calmer cocoa outlook.

Bioversys Posts Wider H1 Loss, Remains Funded Through 2028
Basel biotech reports CHF 15.6 mln net loss in first half, cites first Shionogi partnership revenue; cash runway extends to late 2028.

US Futures Slip; SMI Tumbles 1.3% on Oil, Rates, Bank Woes
The SMI fell 1.3%, with UBS leading declines as Powell's 5.041% yield and Brent crude near $108 weigh on stocks.

DAX slips 0.4% as oil, AI worries and weak bank shares pressure Frankfurt
German equities fell Tuesday as elevated oil prices, lingering AI concerns and downgrades weighed on banks and chemicals ahead of the Fed's decision.

SMI widens losses; UBS, Partners Group fall; Centiel gains
The Swiss benchmark fell 1.3% as UBS dropped 4%, Brent topped $107 and traders awaited the Fed decision; Centiel rose 7% on a plant acquisition.

German Stocks Fall, DAX Hits 7-Week Low on Oil and Rate Worries
The DAX dropped 0.7% to 25,260 as persistently high oil prices and AI-sector anxieties weighed on European equities. Fed decision looms.

SGS-TÜV Saar listed by Germany's KBA for automated vehicle training
The company has been added to the Federal Motor Transport Authority's register of authorized technical services for GRA training, expanding its vehicle homologation offerings.

